At the APHA 2019 Conference, Health Union published an abstract using patient-generated data from their syndicated research findings, Bladder Cancer In America 2018. The study aimed to describe the disparity that exists between healthcare professionals (HCPs) and discussions around potential sexual side effects of bladder cancer treatment among male patients compared to female patients.

The results of the study displayed that of the respondents with bladder cancer who underwent surgery (n=312), 24% experienced sexual side effects and discussions regarding potential side effects on sex with an HCP occurred more frequently with male patients compared to female patients (n=309).

Read the full abstract on gender disparities in HCP discussions about sex side effects among patients with bladder cancer here.